• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    Device to Release Electromagnetic Radiation in the Iris of the Human Eye. Rather than relying exclusively on pupil occlusion or eye movement tracking to protect the fundus from accidental exposure to electromagnetic radiation, the present invention also uses an electromagnetic radiation pathway with a profile such that the energy density in the iris is greater than the energy density in the posterior portion of the eye. This disparity in energy density allows for efficacy at the site of the treatment of the anterior iris, without prejudice to the fundus.
    公开号:BR112014026189B1
    申请号:R112014026189-0
    申请日:2013-04-25
    公开日:2021-01-19
    发明作者:Gregg Homer
    申请人:Gregg Homer；
    IPC主号:
    专利说明:

    DESCRIPTIVE REPORT Reference to Related Orders
    [0001] This patent application claims priority of US patent application 13 / 456,111, filed on April 25, 2012, which is incorporated by reference, along with all other references cited in this patent application. Fundamentals of the Invention
    [0002] There are several new ophthalmic procedures that require uniform application of electromagnetic radiation to a large portion of the human iris. Examples of these procedures include the laser color changing eye method described in US Patents 6,912,528 (issued June 28, 2005) and 8,206,379 (issued June 26, 2012), granted to the Applicant and the method for the treatment of glaucoma described in US patent application 13 / 456,111, filed by the Applicant. Another example of these procedures is a new treatment for presbyopia developed by the Applicant by means of which electromagnetic radiation is applied to the portion of the anterior iris to the constricting pupillary muscles, thereby reducing the size of the pupil and increasing the depth of field of acuity. patient's visual.
    [0003] The uniform application of electromagnetic radiation to the iris usually requires the use of a computerized scanning system to direct the path of electromagnetic radiation through the iris in a predetermined pattern.
    [0004] The application of electromagnetic radiation to a large portion of the human iris poses a significant risk of accidental exposure of electromagnetic radiation into the eye socket, including the fundus (which includes the retina, optic nerve, macula, fovea and posterior pole). Exposure to these areas can cause permanent vision problems or loss.
    [0005] There are already several methods to protect the fundus against accidental exposure to electromagnetic radiation. One such method comprises the occlusion of the pupil during the application of electromagnetic radiation to the anterior iris. As an example, in US Patent No. 8,206,379, Applicant discloses the application to the iris of a contact lens having a physical occlusion to block the path of electromagnetic radiation as it moves through the anterior iris. Another method is to establish a predetermined application pattern, which prevents the pupil from following any movement of the eye during treatment and suspends or interrupts exposure (passive tracking) or shifts the position of the treatment pattern (active tracking) in the case of movements of the eye. eye. Passive and active eye detection technologies are well known in the art and readily available commercially. As an example, SensoMotoric Instruments GmbH (Teltow, Germany) integrates its SMI Surgery Guidance active eye tracking technology into computer-guided laser systems for procedures such as corneal surgery, intraocular lens implant surgery. Another example is the OneK + active eye tracker from Chronos Vision GmbH (Berlin, Germany) for use in connection with computer-guided refractive laser eye surgery. The problem with these methods to reduce the risk of accidental fundus exposure is that none of them can guarantee success 100% of the time. Contact lenses can move during surgery, thus leaving the pupil unprotected and the fundus subject to accidental exposure. Eye tracking, while now highly advanced, is susceptible to mechanical and calculation errors that could result in fundus exposure. In addition, the response time of eye tracking systems is often not fast enough to change the pattern of treatment before accidental exposure.
    [0006] There is a need, therefore, for a device that provides uniform application of electromagnetic radiation to the anterior surface of the human iris through the use of a computer-guided system, without subjecting the eye fundus to accidental exposure. Brief Summary of the Invention
    [0007] Rather than relying exclusively on pupil occlusion or eye movement tracking to protect the eye fundus from accidental exposure to electromagnetic radiation, the present invention also uses an electromagnetic radiation pathway with a profile such that the density of energy in the iris is greater than the energy density in the posterior portion of the eye. This disparity in energy density allows for efficacy at the site of the treatment of the anterior iris, without prejudice to the fundus.
    [0008] In one embodiment of the invention, electromagnetic radiation comprises light waves. In one version of this modality, the electromagnetic radiation generator is a laser and the electromagnetic radiation pathway is a laser beam. The computerized scanning system applies the laser beam to the anterior surface of the iris. The laser beam profile is Gaussian, in such a way that the beam profile converges to a focal point and then diverges from the focal point. Due to the profile of the laser beam, the energy density in the anterior iris is greater than the energy density in the back of the eye. In alternative independent versions of this modality, the beam divergence angle is 1.0-2.5 degrees, 2.5-5.0 degrees, 5.0-7.5 degrees, 7.5-10.0 degrees, 10.0-12.5 degrees, 12.5-15.0 degrees, 15.0-20.0 degrees, or greater than 20.0 degrees.
    [0009] Computerized scanning systems are well known in the art. The verification system can be implemented using one or more computer systems. An exemplary computer system can include software, monitor, case, keyboard and mouse. The cabinet can house known computer components, such as a processor, memory, mass storage devices and the like. The beam can be oriented in any shape or pattern, including, but not limited to, a spiral pattern, a raster pattern, or a segregated regional pattern.
    [00010] In another version of the previous modality, the anterior iris is divided into two treatment zones, each zone being concentric to the pupil. The first treatment zone extends approximately from the outer periphery of the pupil's constricting muscles to the outer periphery of the pupil. The second treatment zone extends approximately from the limbus to the outer periphery of the pupil's constricting muscles. The computerized scanning system applies the first laser beam to the first treatment zone, in a spiral pattern, from the outer periphery to the inner periphery and the second to the second treatment zone, in a spiral pattern, from the outer periphery to the inner periphery.
    [00011] In another embodiment of the invention, electromagnetic radiation comprises sound waves. In a version of this modality, the electromagnetic radiation generator is a sound amplification by stimulated radiation emission (or SASER) and the electromagnetic radiation pathway is a SASER beam. The computerized scanning system applies the SASER beam to the anterior surface of the iris. The profile of the SASER beam is Gaussian, in such a way that the beam profile converges to a focal point and then diverges from the focal point. Due to the profile of the SASER beam, the energy density in the anterior iris is greater than the energy density in the back of the eye.
    [00012] In another embodiment of the invention, an application of electromagnetic radiation overlaps with a previous application of electromagnetic radiation within a period of 24 hours. In the laser mode above, for example, a laser dot is applied in a way that overlaps a laser dot previously applied within a 24 hour period. In another embodiment, an application of electromagnetic radiation is applied in a manner that does not overlap with any previous application of electromagnetic radiation within a period of 24 hours. In the above laser mode, a laser dot is applied in a way that does not overlap with any laser dot previously applied within a 24 hour period. In yet another embodiment, an application of electromagnetic radiation leaves an area of the untreated iris between said previous application and all applications of electromagnetic radiation within a period of 24 hours. In the above laser modality, a laser spot is applied in a way that leaves an untreated iris area between that spot and all the laser spots previously applied in a 24-hour period. And in another modality, some applications of electromagnetic radiation overlap with previous applications and others do not, in a period of 24 hours. In the laser mode above, some laser points overlap with the previous laser points and others do not, within a 24-hour period.
    [00013] In another embodiment of the invention, the device includes a device for restricting the movement of the head during the procedure. In one version of this modality, head movement is restricted using a surgical head restraint. Retains the surgical head is well known in the art. In another version of this modality, a toothed bar is used to restrict the movement of the head during the procedure. Use of a toothed bar to restrict movement of the head is well known in the art, including the use of a toothed bar during brain imaging. In yet another version of this modality, a head fixation target is used to restrict the movement of the head during the procedure. The head fixation target is a new device invented by the Applicant. It uses one or more rods, bars, or strips, made of any metal, fabric, plastic, or any other material, to apply pressure to predetermined points on the patient's head, thus providing feedback to the patient regarding to any movement.
    [00014] In another embodiment of the invention, the device includes a device to restrict movement of the eye during the procedure. In one version of this modality, the movement of the eye is restricted using a suction ring. Ophthalmic suction rings are well known in the art. In another version, movement is restricted using a gaze target. The fixation of the gaze is well known in the art. The fixation of the gaze can use any fixation object, including, among others, a three-dimensional object, a two-dimensional image or a light. In a new variation on this version of this modality invented by the Applicant, a light source is placed at the end of a tube, in such a way that the patient must look through the tube in order to see the light source. In addition to providing a fixation target for the eye, this variation also provides a fixation target for the head, because if the patient moves off-axis, the light source will no longer be visible. In another new variation of this version of this modality invented by the Applicant, the light produced by the light source changes color during the procedure. The light can, for example, vary between orange, red, green, white and yellow. A color-changing fixation target is less likely to induce involuntary saccadic movement or other eye movement in order to refresh the image on the retina or, alternatively, the discomfort that comes with suppressing such movement. In another new variation of this new version of this modality invented by the Applicant, the light produced by the light source changes in intensity during the procedure. The light can, for example, alternate between bright, medium and dark. An intensity-altering fixation target is also less likely to induce involuntary saccadic movement or other eye movements in order to update the image on the retina or, alternatively, the discomfort that comes with suppressing such movement. In yet another new variation in this version of this modality invented by the Applicant, the fixation target comprises a moving image, whose image can be animated or live action, in color or in black and white, in two or three dimensions. A moving image fixation target is also less likely to induce involuntary saccadic movements or other eye movements in order to update the image on the retina or, alternatively, the discomfort that comes with suppressing such movement. Either of these modalities, variations, or versions can be placed in front of the treated eye, or the other eye during the procedure, in order to obtain a fixation of the treated eye.
    [00015] In another embodiment of the invention, the device includes an apparatus for detecting eye movement during treatment. In one version of this modality, active eye tracking is used, whereby the movement of the eye is identified and the electromagnetic path is moved to match the movement of the eye. These movements may consist of displacements along the anterior surface of the iris (along the so-called x-y plane), changes in depth (along the so-called z-axis), rotations around the orbital axis, or otherwise. Active eye tracking is well known in the art. In another version of this modality, passive eye tracking is used, whereby the movement of the eye is identified and the path of electromagnetic radiation is terminated or suspended. In a new variant of this version of this modality invented by the Applicant, the movement of the eye is identified and the path of electromagnetic radiation is suspended until the eye returns to its previous position or assumes another desired position, in which time the path of electromagnetic radiation is resumed. In independent alternative variations on these versions of this modality, the path of electromagnetic radiation is terminated or suspended by (a) terminating or suspending the supply of the source of electromagnetic radiation, (b) disconnecting the source of electromagnetic radiation, (c) redirecting the path of electromagnetic radiation outside the target area, (d) use of the shutter, deflector, shield, or other occlusion device to interrupt the path of electromagnetic radiation, or (e) use of an optical modulator (such as an acoustic modulator). optical or an electro-optical modulator) or other energy modulator to interrupt the path of electromagnetic radiation.
    [00016] Other objects, characteristics and advantages of the present invention will be apparent after considering the following detailed description and the accompanying drawings, in which reference designations represent similar characteristics throughout the figures. Brief Description of Drawings
    [00017] Figure 1 shows aspects of an embodiment of the invention, in which the profile of the electromagnetic radiation pathway is such that the energy density in the diaphragm is greater than the energy density in the posterior portion of the eye.
    [00018] Figure 2 shows the aspects of a modality of the invention, in which the anterior iris is divided into two treatment zones, each zone being concentric to the pupil.
    [00019] Figure 3 shows the aspects of a modality of the invention, in which an application of electromagnetic radiation overlaps with a previous application of electromagnetic radiation.
    [00020] Figure 4 shows aspects of an embodiment of the invention, in which electromagnetic radiation is applied in a manner that does not overlap with any previous application of electromagnetic radiation.
    [00021] Figure 5 shows the aspects of a modality of the invention, in which electromagnetic radiation is applied in a way that leaves an untreated area of the iris between said application and all previous applications of electromagnetic radiation.
    [00022] Figure 6 presents some aspects of an embodiment of the invention, in which a new head fixation target is used to restrict the movement of the head of the head during the procedure. Detailed Description of the Invention
    [00023] Rather than relying solely on pupil occlusion or eye movement tracking to protect the eye fundus from accidental exposure to electromagnetic radiation, the present invention also uses an electromagnetic radiation pathway with a profile such that the energy density in the iris is greater than the energy density in the posterior portion of the eye. See, for example, Fig. 1 This disparity in energy density allows efficacy at the site of the previous treatment of the iris, without prejudice to the fundus.
    [00024] As used in this disclosure, "electromagnetic radiation" includes any form of electromagnetic radiation, in the form of sound, light, heat, or other and consisting of radio frequency, ultrasound, microwave, infrared light, visible, ultraviolet light. , X-rays, T-rays, gamma rays, or others. The term “electromagnetic radiation” is not intended to limit the form of radiation in terms of monochromaticity (that is, composed of one or more than a different wavelength), directional (that is, it produces a single point that does not diverge or if propagates in several different directions), or coherence (that is, the waves produced consist of a single-phase relationship or of multiple-phase relationships). In addition, the frequency of electromagnetic radiation can be any frequency within the electromagnetic spectrum, including, but not limited to, extremely low frequency sound radiation (with a frequency of 3 Hz) to gamma radiation (with a frequency of 300 EHz). Electromagnetic radiation can be delivered in a continuous wave or by pulses and the pulse width can be of any length of time, including microseconds, nanoseconds, picoseconds, femtoseconds or attoseconds. If pulsed, any repetition rate can be used, including, but not limited to, repetition rates from 1 Hz to 100 THz. In addition, any power output can be used and any energy density can be created at the target treatment site, including, but not limited to, power outputs from 1 W to 1000 W. Finally, any means of gain can be used. used, including but not limited to glass, solid, liquid, gaseous, crystal, or semiconductor. In the case of laser energy, the specific gain medium can include Nd: YAG, alexandrite, pulsed-dye, or any other medium.
    [00025] The term "laser" includes any form of radiation in the light spectrum, which consists of infrared, visible, ultraviolet, or other light. The term "laser" is not intended to limit the form of radiation in terms of monochromaticity (that is, composed of one or more than a different wavelength), directionality (that is, to produce a single point that is not divergent or that propagates in several different directions), or coherence (that is, the waves produced consist of a single-phase relationship or of multiple-phase relationships). Laser radiation can be released in a continuous wave or in pulses and the pulse width can be any length of time, including microseconds, nanoseconds, picoseconds, femtoseconds or attoseconds. If pulsed, any repetition rate can be used, including, but not limited to, repetition rates from 1 Hz to 100 THz. In addition, any power output can be used and any energy density can be created at the target treatment site, including, but not limited to, power outputs from 1 W to 1000 W. Finally, any means of gain can be used. used, including, but not limited to, glass, solid, liquid, gaseous, crystal, or semiconductor, and, more specifically, Nd: YAG, alexandrite, pulsed, or any other medium.
    [00026] The term “pathway” includes any pathway of electromagnetic radiation, such as a laser beam, radiofrequency pathway, via SASER, via ultrasound, via microwave, via infrared, via visible light, via ultraviolet, via x-ray, t-ray, gamma-ray, or other. In addition, electromagnetic radiation can be fully collimated or any divergence or convergence drainage angle. Finally, the term "pathway" must be understood to include a single pathway or multiple pathways and multiple pathways may result from the division or tracking of a single pathway or the generation of multiple pathways with multiple frequencies, shapes, energy densities and other features. If the pathway is a laser beam, it may or may not be fired using a goniolent.
    [00027] The term "point" includes the intersection plane between the pathway and the target cells or tissue, such as the laser point, radio frequency location, SASER location, ultrasound location, microwave location, infrared location , visible light spot, ultraviolet spot, X-ray spot, t-ray spot, gamma-ray spot, or others. The term "electromagnetic radiation" is not intended to limit the path or point to a particular shape, size, or projection angle. Points can be tangent, overlapping, or isolated and overlapping can occur in any direction (x, y, or z). They can also be square, rectangular, circular, elliptical, triangular, trapezoidal, torus, or other shapes. Finally, a point can measure any diameter, including but not limited to 1-10 microns, 10-50 microns, 50-100 microns, 100-200 microns, 200-500 microns, 500-1,000 microns or 1,000 microns at 15 mm.
    [00028] Preferably, the energy density of the pathway is set at a level that minimizes undesirable damage to the eye tissue. Although the preferred frequencies of electromagnetic radiation will pass through the cornea, without causing any injury to the cornea, the method of the present invention may still include creating an opening in the cornea before applying electromagnetic radiation. Once the opening has been created, electromagnetic radiation can be introduced directly through the opening or via a pathway vehicle, such as the conductive light fiber. If necessary, a temporary contact lens can be applied to reduce postoperative discomfort.
    [00029] In one embodiment of the invention, electromagnetic radiation comprises light waves. In one version of this modality, the electromagnetic radiation generator is a laser and the electromagnetic radiation pathway is a laser beam. The computerized scanning system applies the laser beam to the anterior surface of the iris. The laser beam profile is Gaussian, in such a way that the beam profile converges to a focal point and then diverges from the focal point. See Fig. 1. Due to the laser beam profile, the energy density in the anterior iris is greater than the energy density in the fundus. In alternative versions of this independent modality, the beam divergence angle is 1.0-2.5 degrees, 2.5-5.0 degrees, 5.0-7.5 degrees, 7.510.0 degrees, 10.0- 12.5 degrees, 12.5-15.0 degrees, 15.0-20.0 degrees, or greater than 20.0 degrees. In other alternative independent versions of this modality, the spot produced by the laser beam on the anterior surface of the iris has a diameter of 1-10 microns, 10-50 microns, 50-100 microns, 100-200 microns, 200-500 microns, 500-1,000 microns and 1,000 microns at 15 millimeters.
    [00030] Computerized scanning systems are well known in the art. See, for example, Zyoptix Custom Wavefront LASIK (Bausch & Lomb, Rochester, NY). The scanning system can be implemented using one or more computer systems. An exemplary computer system can include software, monitor, case, keyboard and mouse. The cabinet can house known computer components, such as a processor, memory, mass storage devices and the like. Mass storage devices can include mass disk drives, floppy disks, Iomega ZIP.TM disks, magnetic disks, fixed disks, hard disks, CD-ROMs, recordable CDs, DVDs, DVD-R, DVD-RW, Flash and others non-volatile solid state storage media, tape storage, reader and the like and combinations thereof. A binary machine executable version of the software of the present invention can be stored or reside on mass storage devices. In addition, the source code of the software of the present invention can also be stored or reside on mass storage devices (for example, a magnetic disk, a tape or a CD-ROM). In addition, a computer system can include subsystems, such as central processor, system memory, input / output (I / O) controller, video adapter, serial or universal serial bus (USB) port, interface network and speaker. The present invention can also be used with computer systems with additional or less subsystems. For example, a computer system may include more than one processor (that is, a multiprocessor system) or a system may include cache memory. The beam can be oriented in any shape or pattern, including, but not limited to, a spiral pattern, a frame pattern, or a segregated regional pattern.
    [00031] In another version of the previous modality, the anterior iris is divided into two treatment zones, each zone being concentric to the pupil. See Fig. 2 The first treatment zone extends approximately from the outer periphery of the pupil constrictor muscles to the outer periphery of the pupil. The second treatment zone extends approximately from the limbus to the outer periphery of the pupil's constricting muscles. The computerized laser beam scanning system is applied first to the first treatment zone, in a spiral pattern, from the outer periphery to the inner periphery and the second to the second treatment zone, in a spiral pattern, starting from from the outer periphery to the inner periphery.
    [00032] In another embodiment of the invention, electromagnetic radiation comprises sound waves. In a version of this modality, the electromagnetic radiation generator is a SASER and the electromagnetic radiation pathway is a SASER beam. The computerized scanning system applies the SASER beam to the anterior surface of the iris. The profile of the SASER beam is Gaussian, in such a way that the beam profile converges to a focal point and then diverges from the focal point. See Fig. 1. Due to the profile of the SASER beam, the energy density in the anterior iris is greater than the energy density in the fundus. In alternative versions of this independent modality, the beam divergence angle is 1.0-2.5 degrees, 2.5-5.0 degrees, 5.0-7.5 degrees, 7.510.0 degrees, 10.0- 12.5 degrees, 12.5-15.0 degrees, 15.0-20.0 degrees, or greater than 20.0 degrees. See Fig. 1 According to other independent alternative versions of this modality, the point produced by the SASER beam on the anterior surface of the iris has a diameter of 1-10 microns, 10-50 microns, 50-100 microns, 100-200 microns, 200-500 microns, 5001,000 microns and 1,000 microns at 15 millimeters.
    [00033] In alternative embodiments independent of the invention, electromagnetic radiation is applied to a percentage of the total area of the anterior surface of the iris equal to 1-25%, 25-50%, 50-75%, or 75-100%.
    [00034] In another embodiment of the invention, an application of electromagnetic radiation overlaps with a previous application of electromagnetic radiation within a period of 24 hours. See Fig. 3 In the above laser mode, for example, a laser dot is applied in a way that overlaps a laser dot previously applied within a 24 hour period. In other independent alternative versions of this variant, a site overlaps a site previously applied within a period of 24 hours by a percentage of the area of the previous site equal to 0-10%, 10-20%, 2030%, 30-40 %, 40-50%, 50-60%, 60-70%, 70-80%, 80-90%, or 90 100%. In another embodiment, electromagnetic radiation is applied in a way that does not overlap with any previous application of electromagnetic radiation within a 24-hour period. See Fig. 4 In the laser mode above, a laser point is applied in a way that no laser point previously applied within a 24-hour period overlap. In yet another embodiment, an application of electromagnetic radiation leaves an untreated area of the iris between said application and all previous applications of electromagnetic radiation within a period of 24 hours. See Fig. 5 In the above laser mode, a laser spot is applied in a way that leaves an untreated iris area between that spot and all previously applied laser spots within a 24 hour period. In other alternative independent versions of this variant, a point is applied in a way that leaves a distance between that point and all previously applied laser points within a period of 24 hours equivalent to 1-10 microns, 10-50 microns, 50- 100 microns, 100-200 microns, 200-500 microns, 500-1,000 microns and 1,000 microns at 15 millimeters. And in another modality, some applications of electromagnetic radiation overlap with previous applications and others do not, in a period of 24 hours. In the laser mode above, some laser points overlap with the previous laser points and others do not, within a 24-hour period.
    [00035] In another embodiment of the invention, the device includes a device for restricting the movement of the head during the procedure. In one version of this modality, head movement is restricted using a surgical head restraint. Surgical head restraint is well known in the art. Examples include the Surgical Head Restraint System (RTP Company, Winona, MN) and head restraining tapes (Equip. No. BF039) for use with the Cmax Shoulder Chair (Equip. No. BF594) (Steris Corporation, Mentor, OH ). In another version of the present modality, a toothed bar is used to restrict the movement of the head during the procedure. Use of a toothed bar to restrict movement of the head is well known in the art, including the use of a toothed bar during brain imaging. See, for example, Menon, et al., Design and efficacy of a head-coil bite bar for reducing movement-related artifacts during functional MRI scanning, 29 Behav. Res. Meth., Instr., & Comp. 589-94 (1997). In yet another version of this modality, a head fixation target is used to restrict the movement of the head of the head during the procedure. The head fixation target is a new device invented by the Applicant. It uses one or more rods, bars, or strips, made of any metal, fabric, plastic, or any other material, to apply pressure to predetermined points on the patient's head, thus providing feedback to the patient regarding to any movement. See Fig. 6.
    [00036] In another embodiment of the invention, the device includes a device to restrict movement of the eye during the procedure. In one version of this modality, the movement of the eye is restricted using a suction ring. Ophthalmic suction rings are well known in the art. See Corneal Surgery: Theory, Technique, and Tissue 722 (Brightbill, ed, 4th ed, 2009). In another version, movement is restricted using a gaze target. Gaze fixation is well known in the art. See Simonová, Ocular and orbital legions, in Principles and practice of stereotactic radiosurgery 593 (Chin & Regine, eds., 2008). Gaze fixation can use any fixation object, including, but not limited to, a three-dimensional object, a two-dimensional image, or a light. In a new variant of this version of this modality invented by the Applicant, a light source is placed at the end of a tube, in such a way that the patient has to look through the tube in order to see the light source. In addition to providing a gaze fixation target, this variation also provides a head fixation target, because if the patient moves off-axis, the light source will no longer be visible. In another variation of this new version of this modality invented by the Applicant, the light produced by the light source changes color during the procedure. The light can, for example, change between orange, red, green, white and yellow. A color-changing fixation target is less likely to induce involuntary saccadic movements or other eye movements in order to update the image on the retina or, alternatively, the discomfort that comes with suppressing such movement. See Tomimatsu, The “rotating snake” in smooth motion do not appear to rotate, 39 Perception 721-24 (2010). In another new variation of this version of this modality invented by the Applicant, the light produced by the light source changes intensity during the procedure. The light can, for example, alternate between bright, medium and dark. A target for fixing the intensity of change is also less likely to induce involuntary saccadic movements or other eye movements in order to update the image on the retina or, alternatively, the discomfort that comes with suppressing such movement. See id. in 721-24. In yet another new variation in this version of this variant invented by the Applicant, the fixation target comprises a moving image, which image can be animated or live action, in color or in black and white, in two or three dimensions. A moving image fixation target is also less likely to induce involuntary saccadic movements or other eye movements in order to update the image on the retina or, alternatively, the discomfort that comes with suppressing such movement. See id. in 721-24. Either of these modalities, variations, or versions can be placed in front of the treated eye, or the other eye during the procedure, in order to obtain a fixation of the treated eye.
    [00037] In another embodiment of the invention, the device includes an apparatus for detecting eye movement during treatment. In a version of this modality, the monitoring of the active eye is used, whereby the movement of the eye is identified and the electromagnetic path is moved to correspond to the movement of the eye. These movements may consist of displacements along the anterior surface of the iris (along the so-called x-y plane), changes in depth (along the so-called z-axis), rotation around the orbital axis, or otherwise. Active eye tracking is well known in the art. See, for example, SMI Surgery Guidance (SensoMotoric Instruments GmbH, Teltow, Germany). In another version of this modality, passive eye tracking is used, by which the movement of the eye is identified and the path of electromagnetic radiation is interrupted or suspended. In a new variant of this version of this modality invented by the Applicant, the movement of the eye is identified and the path of electromagnetic radiation is suspended until the eye returns to its previous position or takes on another desired position, whereby the time of the path of electromagnetic radiation is resumed. In independent alternative variations on these versions of this modality, the path to electromagnetic radiation is terminated or suspended by (a) terminating or suspending the supply of the source of electromagnetic radiation, (b) disconnecting the source of electromagnetic radiation, (c) redirecting the path of electromagnetic radiation outside the target area, (d) use of a shutter, deflector, shield, or other occlusion device to interrupt the path of electromagnetic radiation, or (e) use of an optical modulator (such as an acoustic modulator). optical or an electro-optical modulator) or other energy modulator to interrupt the path of electromagnetic radiation.
    [00038] In another embodiment of the invention, the device includes infrared iris trans-illumination technology. This technology is well known in the art. See Chan, Digital Camera System to Perform Infrared Photography of Iris Transillumination, 11 J. Glaucoma 426-28 (2002). Many eye tracking technologies use the pupil to track eye movement. In dark irises, however, the pupil can be difficult to locate. Thus, in a new variation in this modality invented by the Applicant, infrared iris transillumination is used to more easily identify the dark iris pupil.
    [00039] In another embodiment of the invention, the device includes an apparatus for measuring the refractive indices of the eye and adjusting the application of light to take into account the refraction of light, during treatment. In a version of this modality, the device measures the depth of the anterior chamber of the eye and adjusts the application of light to take into account the refraction of light, during treatment. Apparatus for measuring the depth of the anterior chamber are well known in the art. Examples include Lenstar® technology from Haag-Streit AG (Koeniz, Switzerland) and IOLMaster® technology from Carl Zeiss Meditec AG (Jena, Germany). In another version of this modality, the device measures the shape of the cornea and adjusts the application of light to take into account the refraction of light, during treatment. Apparatus for measuring the depth of the anterior chamber are well known in the art. Examples include HR Pentacam® technology from OCULUS Optikgerate GmbH (Wetzlar, Germany) and ATLAS ™ 9000 Corneal topography System by Carl Zeiss Meditec AG (Jena, Germany).
    [00040] A person skilled in the art will recognize many other variations, modifications and alternatives. The above examples are merely illustrative, which should not unduly limit the scope of the Claims included herein. It is also understood that the examples and modalities described herein are for illustrative purposes only and that various modifications or changes in the light of them will be suggested to those skilled in the art and should be included in the spirit and scope of this Application and the scope of the appended Claims.
    [00041] This description of the invention has been presented for purposes of illustration and description. It is not intended to be exhaustive or to limit the invention to the precise form described and many modifications and variations are possible in light of the above teachings. The modalities were chosen and described in order to better explain the principles of the invention and their practical applications. The description will enable other persons skilled in the art to make better use and practice the invention in various modalities and with various modifications as they are appropriate for a particular use. The scope of the invention is defined by the following Claims.
    权利要求:
    Claims (21)
    [0001]
    1. Device for Releasing Electromagnetic Radiation to the Anterior Surface of the Iris of the Human Eye, comprising said device: an electromagnetic radiation generator, comprising a laser to generate a laser beam; and a computerized scanning system, configured to apply said laser beam to 50% or more of the anterior surface of the iris; characterized by the fact that the electromagnetic radiation generator is configured to emit the laser beam that converges previously to the iris and delivers to the iris a first energy density, in which in the case of accidental exposure of the bottom to the laser beam, the laser beam diverges posteriorly to the iris and delivers a second energy density to the bottom where the first energy density is greater than the second energy density.
    [0002]
    2. Device for Releasing Electromagnetic Radiation to the Anterior Iris Surface of the Human Eye, according to Claim 1, characterized in that the laser beam later diverges from the iris at an angle of divergence of 1.0-2.5 degrees.
    [0003]
    3. Device for Releasing Electromagnetic Radiation to the Anterior Iris Surface of the Human Eye, according to Claim 1, characterized in that the laser beam later diverges from the iris at a 2.5-5.0 degree angle of divergence.
    [0004]
    4. Device for Releasing Electromagnetic Radiation to the Anterior Iris Surface of the Human Eye, according to Claim 1, characterized in that the laser beam later diverges from the iris at an angle of divergence of 5.0-7.5 degrees.
    [0005]
    5. Device for Releasing Electromagnetic Radiation to the Anterior Iris Surface of the Human Eye, according to Claim 1, characterized in that the laser beam diverges posteriorly to the iris at an angle of divergence of 7.5-10 degrees.
    [0006]
    6. Device for Releasing Electromagnetic Radiation to the Anterior Iris Surface of the Human Eye, according to Claim 1, characterized in that the laser beam diverges posteriorly to the iris at an angle of divergence of 10.0-12.5 degrees.
    [0007]
    7. Device for Releasing Electromagnetic Radiation to the Anterior Iris Surface of the Human Eye, according to Claim 1, characterized in that the laser beam diverges posteriorly to the iris at a 12.5-15.0 degree divergence angle.
    [0008]
    8. Device for Releasing Electromagnetic Radiation to the Anterior Iris Surface of the Human Eye, according to Claim 1, characterized in that the laser beam later diverges from the iris at an angle of divergence of 15.0-20.0 degrees.
    [0009]
    9. Device for Releasing Electromagnetic Radiation to the Anterior Iris Surface of the Human Eye, according to Claim 1, characterized in that the laser beam later diverges from the iris at an angle of divergence greater than 20.0 degrees.
    [0010]
    10. Device for Releasing Electromagnetic Radiation to the Anterior Iris Surface of the Human Eye, according to any one of the preceding Claims, characterized in that the electromagnetic radiation is applied to a percentage of the anterior surface of the iris equal to 50-75%.
    [0011]
    11. Device for Releasing Electromagnetic Radiation to the Anterior Iris Surface of the Human Eye, according to any one of Claims 1 to 9, characterized in that the electromagnetic radiation is applied to a percentage of the anterior surface of the iris equal to 75-100 %.
    [0012]
    12. Device for Releasing Electromagnetic Radiation to the Anterior Iris Surface of the Human Eye, according to any one of Claims 1 to 11, characterized in that the computerized scanning system is configured to apply a first laser point and a second point laser on the anterior surface of the iris.
    [0013]
    13. Device for Releasing Electromagnetic Radiation to the Anterior Iris Surface of the Human Eye, according to any one of Claims 1 to 12, characterized in that the laser beam produces a spot on the anterior surface of the iris with a diameter of 1 -10 microns.
    [0014]
    14. Device for Releasing Electromagnetic Radiation to the Anterior Iris Surface of the Human Eye, according to any one of Claims 1 to 12, characterized in that the laser beam produces a point on the anterior surface of the iris with a diameter equal to 10 -50 microns.
    [0015]
    15. Device for Releasing Electromagnetic Radiation to the Anterior Iris Surface of the Human Eye, according to any one of Claims 1 to 12, characterized in that the laser beam produces a spot on the anterior surface of the iris with a diameter of 50 -100 microns.
    [0016]
    16. Device for Releasing Electromagnetic Radiation to the Anterior Iris Surface of the Human Eye, according to any one of Claims 1 to 12, characterized in that the laser beam produces a spot on the anterior surface of the iris with a diameter equal to 100 -200 microns.
    [0017]
    17. Device for Releasing Electromagnetic Radiation to the Anterior Iris Surface of the Human Eye, according to any one of Claims 1 to 12, characterized in that the laser beam produces a point on the anterior surface of the iris with a diameter of 200 -500 microns.
    [0018]
    18. Device for Releasing Electromagnetic Radiation to the Anterior Iris Surface of the Human Eye, according to any one of Claims 1 to 17, characterized in that the device further comprises a gaze fixation target.
    [0019]
    19. Device for Releasing Electromagnetic Radiation to the Anterior Iris Surface of the Human Eye, according to any one of Claims 1 to 18, characterized in that the apparatus includes an apparatus configured to detect movement of the eye during treatment.
    [0020]
    20. Device for Releasing Electromagnetic Radiation to the Anterior Iris Surface of the Human Eye, according to Claim 19, characterized in that the apparatus is further configured to change the direction of the laser beam to correspond to the movement of the eye.
    [0021]
    21. Device for Releasing Electromagnetic Radiation to the Anterior Iris Surface of the Human Eye, according to any one of Claims 1 to 19, characterized in that it further comprises at least one of the following: (a) a device for restricting the movement of the eye during the procedure, comprising at least one of a suction ring affixable to the eye or a gaze fixation target, or (b) a device for detecting eye movement during treatment, where eye movement is identified along of at least one of the xy plane or z axis in the event that eye movement is detected during treatment, the laser beam is at least one that has been moved to match the movement of the eye, either terminated or suspended.
    类似技术:
    公开号 | 公开日 | 专利标题
    BR112014026189B1|2021-01-19|DEVICE TO RELEASE ELECTROMAGNETIC RADIATION TO THE PREVIOUS SURFACE OF THE HUMAN EYE IRIS
    US20140148737A1|2014-05-29|Application of Electromagnetic Radiation to the Human Iris
    US20180207029A1|2018-07-26|Glaucoma treatmentmethods and apparatus
    ES2833281T3|2021-06-14|Devices to improve eyesight using laser photomyosis
    US7803103B2|2010-09-28|Methods and apparatus for intraocular brachytherapy
    JP4602356B2|2010-12-22|Method and apparatus for intraocular brachytherapy
    PT2148628T|2017-12-06|A method and a system for laser photoablation within a lens
    CN104545788B|2017-01-04|A kind of motion feature based on eyeball real-time positioning system to Intraocular Tumor region
    BR112021004204A2|2021-05-25|system and surgical procedure for accurate intraocular pressure reduction
    US10420676B2|2019-09-24|Ophthalmic treatment device, method for controlling ophthalmic treatment device, and fundus lesion treatment method
    BR112021004197A2|2021-05-25|non-invasive and minimally invasive laser surgery to reduce intraocular pressure in the eye
    JP2020507416A|2020-03-12|Method for treating an eye using a wide area light source and an eye mask device
    Rüegsegger et al.2014|Noninvasive referencing of intraocular tumors for external beam radiation therapy using optical coherence tomography: a proof of concept
    KR20180021692A|2018-03-05|Ophthalmic Laser Surgery Equipment for Orthopedic Corneal Correction
    Leibowitz et al.1969|The retinal pigment epithelium: radiation thresholds associated with the Q-switched ruby laser
    US20210369108A1|2021-12-02|Systems and Methods for Eye Tracking During Eye Treatment
    RU2455968C1|2012-07-20|Method of laser surgical treatment of focal chorioretinitis
    WO2022018525A1|2022-01-27|Automated capsulotomy
    同族专利:
    公开号 | 公开日
    IL235278A|2020-09-30|
    PL3517081T3|2021-05-04|
    EP2770960A4|2014-12-31|
    KR20150004887A|2015-01-13|
    US20130289450A1|2013-10-31|
    HUE052402T2|2021-04-28|
    EP3517081B1|2020-11-25|
    ES2737736T3|2020-01-15|
    DK3517081T3|2021-01-25|
    MX368771B|2019-10-02|
    ES2849648T3|2021-08-19|
    PL2770960T3|2019-10-31|
    ES1128330Y|2015-01-21|
    CA2873987A1|2013-10-31|
    CN104271086A|2015-01-07|
    SG10201900957PA|2019-03-28|
    IL235278D0|2014-12-31|
    US10744034B2|2020-08-18|
    ZA201407882B|2015-10-28|
    EP3517081A1|2019-07-31|
    KR102335593B1|2021-12-06|
    CA2873987C|2021-02-23|
    ES1128330U|2014-10-13|
    HK1205672A1|2015-12-24|
    KR20200090930A|2020-07-29|
    JP6735560B2|2020-08-05|
    PT2770960T|2019-07-26|
    EP2770960B1|2019-05-01|
    CN104271086B|2017-11-14|
    PT3517081T|2021-02-04|
    KR102292728B1|2021-08-23|
    JP2015518405A|2015-07-02|
    TR201910959T4|2019-08-21|
    BR112014026189A2|2017-06-27|
    SG11201406667PA|2014-11-27|
    DK2770960T3|2019-07-29|
    MX2014012540A|2015-09-07|
    CN107714280A|2018-02-23|
    EP2770960A1|2014-09-03|
    JP2019134957A|2019-08-15|
    HK1252081A1|2019-05-17|
    WO2013163483A1|2013-10-31|
    HUE045507T2|2019-12-30|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    SU446981A1|1972-08-31|1976-07-05|Предприятие П/Я Г-4147|Laser ophthalmic installation|
    DE3069080D1|1979-11-28|1984-10-04|Lasag Ag|Observation device for eye-treatment|
    US4538608A|1984-03-23|1985-09-03|Esperance Jr Francis A L|Method and apparatus for removing cataractous lens tissue by laser radiation|
    US4791927A|1985-12-26|1988-12-20|Allied Corporation|Dual-wavelength laser scalpel background of the invention|
    US5259380A|1987-11-04|1993-11-09|Amcor Electronics, Ltd.|Light therapy system|
    US4907586A|1988-03-31|1990-03-13|Intelligent Surgical Lasers|Method for reshaping the eye|
    US5152760A|1989-03-17|1992-10-06|The General Hospital Corporation|Non-invasive sclerostomy|
    US5129895A|1990-05-16|1992-07-14|Sunrise Technologies, Inc.|Laser sclerostomy procedure|
    WO1992016259A1|1991-03-13|1992-10-01|Iris Medical Instruments, Inc.|Contact probe for laser cyclophotocoagulation|
    JPH07503382A|1991-11-06|1995-04-13|
    US5370641A|1992-05-22|1994-12-06|O'donnell, Jr.; Francis E.|Laser trabeculodissection|
    US5549596A|1993-07-07|1996-08-27|The General Hospital Corporation|Selective laser targeting of pigmented ocular cells|
    US6059772A|1995-03-10|2000-05-09|Candela Corporation|Apparatus and method for treating glaucoma using a gonioscopic laser trabecular ablation procedure|
    US5549598A|1995-05-22|1996-08-27|O'donnell, Jr.; Francis E.|Glaucoma laser trabeculodissection|
    US6220247B1|1997-10-20|2001-04-24|Arturo Rodolfo Del Rosario Maldonado Bas|Method of treatment of glaucoma with an excimer laser|
    US6319274B1|1998-06-22|2001-11-20|John H. Shadduck|Devices and techniques for light-mediated stimulation of trabecular meshwork in glaucoma therapy|
    US6530916B1|1999-11-15|2003-03-11|Visx, Incorporated|Uniform large area ablation system and method|
    US6912528B2|2000-01-18|2005-06-28|Gregg S. Homer|Rechargeable media distribution and play system|
    US8206379B2|2001-02-02|2012-06-26|Homer Gregg S|Techniques for alteration of iris pigment|
    US6923802B2|2000-03-13|2005-08-02|Memphis Eye & Cataract Assoc.|System for generating ablation profiles for laser refractive eye surgery|
    AU2001257478B8|2000-05-09|2005-07-14|Memphis Eye & Cataract Associates Ambulatory Surgery Center |Method and system for control of high resolution high speed digital micromirror device for laser refractive eye surgery|
    DE10022995C2|2000-05-11|2003-11-27|Wavelight Laser Technologie Ag|Device for photorefractive corneal surgery|
    US6698886B2|2001-04-24|2004-03-02|Ocular Instruments, Inc.|Iridotomy and trabeculoplasty goniolaser lens|
    AT365511T|2002-03-23|2007-07-15|Intralase Corp|SYSTEM FOR IMPROVED MATERIAL PROCESSING WITH A LASER BEAM|
    AU2002951467A0|2002-09-18|2002-10-03|Ellex Medical Pty Ltd|Ophthalmic laser|
    RU2223083C1|2002-09-27|2004-02-10|Московский научно-исследовательский институт глазных болезней им. Гельмгольца|Method for carrying out yag-laser iridectomy|
    US20050043722A1|2003-08-22|2005-02-24|Lin J. T.|Methods and apparatus for treatment of eye disorders using articulated-arm-coupled ultraviolet lasers|
    JP2007518539A|2004-01-22|2007-07-12|ソルクス・インコーポレーテッド|How to treat glaucoma|
    US8394084B2|2005-01-10|2013-03-12|Optimedica Corporation|Apparatus for patterned plasma-mediated laser trephination of the lens capsule and three dimensional phaco-segmentation|
    US20070093794A1|2005-10-14|2007-04-26|Qi Wang|Device, system and method for dual-path ophthalmic device|
    US20070161981A1|2006-01-06|2007-07-12|Arthrocare Corporation|Electrosurgical method and systems for treating glaucoma|
    AU2012261645B2|2006-10-16|2016-01-14|Carl Zeiss Meditec, Inc.|Ocular radiosurgery|
    DK1938839T3|2006-12-18|2009-11-30|Jorge Luis Benozzi|Ophthalmic compositions of parasympathetic stimulants and anti-inflammatory agents for use in the treatment of presbyopia|
    US8568393B2|2007-03-13|2013-10-29|Topcon Medical Laser Systems, Inc.|Computer guided patterned laser trabeculoplasty|
    JP5028124B2|2007-03-29|2012-09-19|株式会社ニデック|Ophthalmic laser treatment device|
    US20100324543A1|2007-09-18|2010-12-23|Kurtz Ronald M|Method And Apparatus For Integrating Cataract Surgery With Glaucoma Or Astigmatism Surgery|
    RU2346677C1|2007-10-10|2009-02-20|Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи"|Method of surgical treatment of angle-closure glaucoma with anular block combined with cyclolenticular and relative pupillary blocks in mongoloids with pseudoexfoliative syndrome|
    IL186598D0|2007-10-11|2008-11-03|Mohammad Abdulrazik|Composition and method for the treatment or prevention of glaucoma and ocular hypertension|
    US8230866B2|2007-12-13|2012-07-31|Carl Zeiss Meditec Ag|Systems and methods for treating glaucoma and systems and methods for imaging a portion of an eye|
    US9492322B2|2009-11-16|2016-11-15|Alcon Lensx, Inc.|Imaging surgical target tissue by nonlinear scanning|
    US20130103011A1|2011-10-21|2013-04-25|Robert Edward Grant|System and Method for Lowering IOP by Creation of Microchannels in Trabecular Meshwork Using a Femtosecond Laser|CN103025282B|2010-05-10|2015-03-11|特拉维夫大学拉玛特有限公司|System for treating glaucoma by directing electromagnetic energy to the limbal area of an eye|
    WO2013126838A2|2012-02-25|2013-08-29|Thrufocus Optics, Inc.|Devices and methods for improving vision using laser photomiosis|
    TWI588560B|2012-04-05|2017-06-21|布萊恩荷登視覺協會|Lenses, devices, methods and systems for refractive error|
    US9541773B2|2012-10-17|2017-01-10|Brien Holden Vision Institute|Lenses, devices, methods and systems for refractive error|
    US9201250B2|2012-10-17|2015-12-01|Brien Holden Vision Institute|Lenses, devices, methods and systems for refractive error|
    CN105050556B|2013-02-26|2017-06-06|贝尔金激光有限公司|For the system of glaucoma treatment|
    WO2017039554A1|2015-08-28|2017-03-09|Kenar Fatih|Iris color changing method|
    US10092397B2|2015-12-30|2018-10-09|Verily Life Sciences Llc|Infrared communication with an opthalmic device|
    US20180104098A1|2016-10-13|2018-04-19|Ronald Michael Kurtz|System for nonpharmacologic long-term constriction of a pupil|
    US10406352B2|2016-10-13|2019-09-10|Ronald Michael Kurtz|System for temporary nonpharmacologic constriction of the pupil|
    US20180104508A1|2016-10-13|2018-04-19|Ronald Michael Kurtz|Optical system for nonpharmacologic constriction of a pupil|
    US10406380B2|2016-10-13|2019-09-10|Ronald Michael Kurtz|Method for nonpharmacologic temporary constriction of a pupil|
    US20180104099A1|2016-10-13|2018-04-19|Ronald Michael Kurtz|Digitally controlled optical system for nonpharmacologic constriction of a pupil|
    US20200253783A1|2017-10-25|2020-08-13|Xinova, LLC|Distributed acoustic detector system|
    ES2715524A1|2017-12-04|2019-06-04|Ruiz Pedro Grimaldos|Laser exlicer specific for therapeutic and cosmetic iridoplasties |
    US11246754B2|2018-07-16|2022-02-15|Vialase, Inc.|Surgical system and procedure for treatment of the trabecular meshwork and Schlemm's canal using a femtosecond laser|
    US11110006B2|2018-09-07|2021-09-07|Vialase, Inc.|Non-invasive and minimally invasive laser surgery for the reduction of intraocular pressure in the eye|
    US11173067B2|2018-09-07|2021-11-16|Vialase, Inc.|Surgical system and procedure for precise intraocular pressure reduction|
    WO2021119626A1|2019-12-14|2021-06-17|Weinstock Robert|Near eye reflective devices for diagnostic and therapeutic ophthalmic procedures|
    US11259962B1|2021-03-24|2022-03-01|Stroma Medical Corporation|Systems and methods for patient alignment and treatment|
    US11160685B1|2021-03-24|2021-11-02|Stroma Medical Corporation|Laser systems and methods for alteration of eye color|
    法律状态:
    2018-12-04| B06F| Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]|
    2019-11-19| B06U| Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]|
    2020-12-22| B09A| Decision: intention to grant [chapter 9.1 patent gazette]|
    2021-01-19| B16A| Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]|Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 25/04/2013, OBSERVADAS AS CONDICOES LEGAIS. |
    优先权:
    申请号 | 申请日 | 专利标题
    US13/456,111|2012-04-25|
    US13/456,111|US10744034B2|2012-04-25|2012-04-25|Method for laser treatment for glaucoma|
    PCT/US2013/038298|WO2013163483A1|2012-04-25|2013-04-25|Application of electromagnetic radiation to the human iris|
    [返回顶部]